SC 13G Filing

Company

PharmaCyte Biotech, Inc.

Filed

October 20, 2022

Accession Number

0001193805-22-001435

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →